KRT6A and cancer: Out of 3515 identified proteins, AHNAK2 and Keratin 6A (KRT6A) were chosen for IHC validation, due to having the highest ratio of means (over 58 and 29 times more abundant in high-grade cancer compared with cystitis) [55].